Capricor Therapeutics, Inc.

CAPRNASDAQHealthcareBiotechnology

$5.74- (-)1Y 0.00%

As of Oct 26, 2026 close

Market cap: $332.50M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $2.96$40.37
Volume (live): -
Avg. volume (3M): 3.27M

Capricor Therapeutics, Inc. (CAPR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Capricor Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Hold

Based on 12 unique analysts

(14 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$27.00

+370.38% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest CAPR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 5, 2026	Boobalan Pachaiyappan	Roth MKM	Maintains	Hold	$7.00
Oct 5, 2026	Joseph Pantginis	HC Wainwright	Maintains	Hold	-
Sep 30, 2026	graywolf	Hot Copper	Initiates Coverage	Buy	-
Sep 28, 2026	Catherine Novack	JonesTrading	Maintains	Hold	-
Sep 14, 2026	Madison Elsaadi	B Riley	Upgrades	Buy	$5.00 → $21.00 +16.00 (+320.0%)
Sep 7, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Sep 1, 2026	Edward Tenthoff	Piper Sandler	Upgrades	Buy	$2.00 → $25.00 +23.00 (+1150.0%)
Aug 25, 2026	Leland Gershell	Oppenheimer	Upgrades	Buy	$54.00
Aug 15, 2026	Jason McCarthy	Maxim	Maintains	Hold	-
Aug 14, 2026	Jason McCarthy	Maxim	Maintains	Hold	-
Aug 14, 2026	Kristen Kluska	Cantor Fitzgerald	Upgrades	Buy	$3.50 → $28.00 +24.50 (+700.0%)
Jul 30, 2026	Rick Bienkowski	Ladenburg Thalmann	Upgrades	Hold	-
Jul 30, 2026	Matthew Venezia	Alliance Global Partners	Maintains	Hold	-
Jul 30, 2026	Catherine Novack	JonesTrading	Upgrades	Hold	-

Boobalan Pachaiyappan

Roth MKM

HoldMaintains

$7.00

Oct 5

Joseph Pantginis

HC Wainwright

HoldMaintains

Oct 5

graywolf

Hot Copper

BuyInitiates Coverage

Sep 30

Catherine Novack

JonesTrading

HoldMaintains

Sep 28

Madison Elsaadi

B Riley

BuyUpgrades

$5.00 → $21.00

Sep 14

Zacks Equity Research

HoldInitiates Coverage

Sep 7

Edward Tenthoff

Piper Sandler

BuyUpgrades

$2.00 → $25.00

Sep 1

Leland Gershell

Oppenheimer

BuyUpgrades

$54.00

Aug 25

Jason McCarthy

Maxim

HoldMaintains

Aug 15

Jason McCarthy

Maxim

HoldMaintains

Aug 14

Kristen Kluska

Cantor Fitzgerald

BuyUpgrades

$3.50 → $28.00

Aug 14

Rick Bienkowski

Ladenburg Thalmann

HoldUpgrades

Jul 30

Matthew Venezia

Alliance Global Partners

HoldMaintains

Jul 30

Catherine Novack

JonesTrading

HoldUpgrades

Jul 30

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CAPR?

The analyst consensus rating for CAPR is Hold, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for CAPR?

The average 12-month price target for CAPR is $27.00, representing an upside of 370.4% from the Oct 26, 2026 close of $5.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.